4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-006576
Chief Financial Officer sold 100,000 shares at an average $56.13 ($5,612,601)
- Chief Financial Officer acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-01-28 | Option exercise | +50,000 | $6.32 | $316,000 | 51,000 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-28 | Sale | −7,779 | $55.04 | $428,156 | 43,221 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-28 | Sale | −23,698 | $56.00 | $1,327,088 | 19,523 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-28 | Sale | −18,523 | $57.00 | $1,055,811 | 1,000 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-29 | Option exercise | +50,000 | $6.32 | $316,000 | 51,000 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-29 | Sale | −38,112 | $55.77 | $2,125,506 | 12,888 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-29 | Sale | −9,704 | $56.68 | $550,023 | 3,184 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-29 | Sale | −2,184 | $57.70 | $126,017 | 1,000 | D |
| Derivatives | |||||||
| Cohen Chad M Chief Financial Officer | 2021-01-28 | Option exercise · Stock Option (Right to Buy) | −50,000 | 115,000 | D | ||
| Cohen Chad M Chief Financial Officer | 2021-01-29 | Option exercise · Stock Option (Right to Buy) | −50,000 | 65,000 | D | ||
| Open-market sales · 100,000 sh · avg $56.13 · $5,612,601 | |||||||
Loading xslF345X03/doc4.xml…